Metastatic Clear-Cell Renal Cell Carcinoma in the Era of Immune Checkpoint Inhibitors: Therapies and Ongoing Trials

SIMPLE SUMMARY: Renal cancer is within the top 10 most common malignancies worldwide, of which clear cell histology represents the most common subtype in this cancer. Within the past few years, immunotherapy has been approved as a first-line therapy for metastatic renal cell carcinoma. Immunotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuang, Tony Zibo, Case, Katherine, Olsen, Timothy Anders, Brown, Jacqueline T., Carthon, Bradley C., Kucuk, Omer, Goldman, Jamie, Harris, Wayne, Bilen, Mehmet Asim, Nazha, Bassel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220801/
https://www.ncbi.nlm.nih.gov/pubmed/35740533
http://dx.doi.org/10.3390/cancers14122867

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220801/
https://www.ncbi.nlm.nih.gov/pubmed/35740533
http://dx.doi.org/10.3390/cancers14122867

Ejemplares similares